| Name | Title | Contact Details |
|---|
Diadexus is a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, providing healthcare providers with actionable information for managing patients. We pioneered the testing of Lp-PLA2 (lipoprotein-associated phospholipase A2), a marker of vascular-specific inflammation that provides new information, over and above traditional risk factors measured in a lipid panel, and has over a decade of peer-reviewed literature validating this biomarker`s utility. Our products are the only two FDA-cleared tests to measure Lp-PLA2: The PLAC® Test ELISA Kit first cleared by the FDA in 2003 and The PLAC® Test for Lp-PLA2 Activity cleared in December 2014. Our pipeline of advanced cardiac biomarkers includes biomarkers for heart failure, proADM, proET-1 and proANP. Each marker gives distinct, additive information for healthcare providers over currently available markers. Diadexus also provides services to pharmaceutical partners to address the need to incorporate biomarkers in clinical development. Our portfolio of advanced cardiac biomarkers is available to be paired with novel therapeutics in development for indications where cardiovascular risk information would provide valuable insights. This information can be used by pharmaceutical companies in targeting the appropriate patient population and understanding the potential long-term side effects for their therapeutics, potentially avoiding long-term follow up studies.
Cambridge Biomedical Inc. is a specialized CRO serving the diverse requirements of the CRO and Biopharmaceutical/Pharmaceutical and Diagnostic markets, utilizing its multi-platform laboratory science capabilities and state of the art systems and procedures. We provide our clients with assay development, assay validation and testing services in support of their clinical trial and pharmaceutical development objectives. Our breadth of experience in laboratory science uniquely positions Cambridge Biomedical to serve as trusted advisor to our clients and provide value-added services beyond the requirements of the project. We are committed to developing each service engagement into a long term relationship.
Cheyenne Womens Clinic PC is a Cheyenne, WY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
New England DNA/ EMSI is a Rocky Hill, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Gelda Scientific is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.